Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Knowing when to start your retirement planning is crucial for financial success. Explore the best times to begin your retirement journey.
18,803 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
A New York-based startup unveiled an autonomous, AI-powered offensive security platform, raising $37 million from Lig...
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
A game-changing cloud contract could reshape SpaceX’s IPO narrative. This article breaks down what google's $920 mill...
Palo Alto Networks reports a milestone milestone: a $10B revenue run rate fueled by platform expansion and AI securit...
Elon Musk asserts a breakthrough AI chip could outpace NVIDIA by 2-3x at a fraction of the cost, aiming for 2027 prod...
A wave of token launches has stumbled, pushing traders toward tokenized stocks. Exchanges are racing to monetize reta...
Anthropic's best ever model claude projects XRP climbing to 4.50 by late 2026, signaling a potential fourfold rally a...
Ethereum faces a potential leap in value as a long-term ZK-based upgrade gains traction. ConsenSys founder Joseph Lub...
SpaceX is courting attention ahead of a potential Nasdaq debut. Some ETFs offer pre-IPO exposure via SPVs, but the st...
A seasoned investor reveals a stubborn bet on Microsoft, arguing that the company’s dual engine—legacy software profi...
Jeff Bezos reveals a bold new venture positioned to accelerate invention cycles and expand global prosperity, challen...